Invesaro

Stocks Health care ECIA

OTC · Health care

Encision Inc (ECIA)

Encision Inc brought in $6.3M of revenue over the twelve months to September 30, 2025, down 3.0% from a year earlier. It posted a net loss of $380.9K. In fiscal 2025 capital spending exceeded operating cash flow by $109.4K. At September 30, 2025 it held $71.7K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 13, 2025.

Watch ECIA in 60 seconds
Price
$0.04
-19.57% on the day · September 25, 2026
52-week range $0.00 to $0.39
Market cap
$693.8K
Revenue (last 12 months)
$6.3M
-3.0% year on year
Net margin
-6.0%

What Encision Inc does

Encision Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker ECIA.

Revenue and profit by year

Revenue
FY18: $8.8M $8.8M FY18FY19: $8.8M $8.8M FY19FY20: $7.7M $7.7M FY20FY21: $7.5M $7.5M FY21FY22: $7.7M $7.7M FY22FY23: $7.3M $7.3M FY23FY24: $6.6M $6.6M FY24FY25: $6.6M $6.6M FY25
Net income
FY18: $335.6K $335.6K FY18FY19: -$236.1K -$236.1K FY19FY20: -$198.3K -$198.3K FY20FY21: $584.7K $584.7K FY21FY22: -$65.6K -$65.6K FY22FY23: -$323.9K -$323.9K FY23FY24: -$691.8K -$691.8K FY24FY25: -$220.2K -$220.2K FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$6.6M-$172K-$220.2K-$0.02-$109.4K
2024$6.6M-$640.8K-$691.8K-$0.06$132.3K
2023$7.3M-$302.8K-$323.9K-$0.03-$1M
2022$7.7M-$594.9K-$65.6K-$0.01-$462K
2021$7.5M-$61.6K$584.7K$0.05$189.9K
2020$7.7M-$156.4K-$198.3K-$0.02-$277.8K

Full financial statements: income, balance sheet and cash flow

Where ECIA ranks in Health care

Revenue$6.6M
#551 of 742 in Health care · Bottom 26%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Encision Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. June 10, 2026
  2. February 4, 2026
  3. February 4, 2026
  4. February 4, 2026
  5. February 4, 2026
  6. February 4, 2026
  7. February 4, 2026
  8. January 29, 2026
  9. January 29, 2026
  10. December 12, 2025

Recent insider filings (Forms 3, 4 and 144): 10, the latest on May 18, 2026. Insider transactions on SEC

Insider trades

What the people running Encision Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
April 16, 2026 Fries Robert HCEO, Director Bought 11,250 $0.20 $2.3K Form 4
April 15, 2026 Fries Robert HCEO, Director Bought 155,535 $0.14 $21.8K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns ECIA

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Trudel Gregory J.13D, may seek influence 8.7% 1,484,072 August 26, 2025
Fries Robert H13D, may seek influence 8.2% 1,380,138 August 26, 2025
Thalassa Holdings, Ltd.13D, may seek influence with 1 related filers 5.21% 619,272 March 7, 2025

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 1,506,785 shares in total, about $61.9K at the last price.

HolderSharesAs of
Fries Robert HCEO, Director 1,506,785 April 16, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about ECIA

What does Encision Inc do?

Encision Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker ECIA.

Is Encision Inc profitable?

No. Over the twelve months to September 30, 2025 it reported a net loss of $380.9K on revenue of $6.3M.

How much revenue does Encision Inc make?

Over the twelve months to September 30, 2025 Encision Inc reported revenue of $6.3M. That is 3.0% less than a year earlier.

When did Encision Inc last report?

Its most recent periodic report is the quarterly report (10-Q) filed on November 13, 2025. It covers the period to September 30, 2025. Its newest filing of any kind is the deregistration (amended) from June 10, 2026.

Similar companies

Compare ECIA with

Compare ECIA with any company

Follow ECIA

Get an email when Encision Inc files with the SEC: results, executive changes, material agreements and annual reports.

Follow ECIA: get an email when it files

Where the numbers come from

Financial figures are the values Encision Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.